Evidence map›Paper›PMID 32486379›Full record

ArticleCells2020

Simon Toupance, Maria G Stathopoulou, Alexandros M Petrelis, Vesna Gorenjak, Carlos Labat, Tsung-Po Lai, Sophie Visvikis-Siest, Athanase Benetos

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Simon ToupanceUniversité de Lorraine, Inserm, DCAC, F-54000 Nancy, France.ORCID 0000-0001-7441-567X
Maria G StathopoulouUniversité de Lorraine, IGE-PCV, F-54000 Nancy, France.
Alexandros M PetrelisUniversité de Lorraine, IGE-PCV, F-54000 Nancy, France.
Vesna GorenjakUniversité de Lorraine, IGE-PCV, F-54000 Nancy, France.
Carlos LabatUniversité de Lorraine, Inserm, DCAC, F-54000 Nancy, France.ORCID 0000-0002-5275-3405
Tsung-Po LaiCenter of Human Development and Aging, Rutgers, New Jersey Medical School, The State University of New Jersey, Newark, NJ 07103, USA.
Sophie Visvikis-SiestUniversité de Lorraine, IGE-PCV, F-54000 Nancy, France.ORCID 0000-0001-8104-8425
Athanase BenetosUniversité de Lorraine, Inserm, DCAC, F-54000 Nancy, France.
Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire · FRInserm · FRRutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Short leukocyte telomere length (LTL) is associated with atherosclerotic cardiovascular disease (ASCVD). Mendelian randomisation studies, using single nucleotide polymorphisms (SNPs) associated with short LTL, infer a causal role of LTL in ASCVD. Recent results, using the blood-and-muscle model, indicate that higher early life LTL attrition, as estimated by the ratio between LTL and skeletal muscle telomere length (MTL), rather than short LTL at conception, as estimated by MTL, should be responsible of the ASCVD-LTL connection. We combined LTL and MTL measurements and SNPs profiling in 402 individuals to determine if 15 SNPs classically described as associated with short LTL at adult age were rather responsible for higher LTL attrition during early life than for shorter LTL at birth. Two of these SNPs (rs12696304 and rs10936599) were associated with LTL in our cohort (

Indexed as

Genetic VariationAdultAgedAged, 80 and overFemaleHumansLeukocytesMaleMiddle AgedMusclesPolymorphism, Single NucleotideRNATelomeraseTelomereTelomere HomeostasisTelomere ShorteningRNATelomerasetelomerase RNAatherosclerosiscohort studiesSNPstelomere length maintenanceTERC

Identifiers

PMID32486379
PMCPMC7349705
OpenAlexW3029953566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.